How effective is Upadacitinib in treating psoriatic arthritis?

UpadacitinibIndicated for the treatment of adults with active psoriatic arthritis who have had an inadequate response to or intolerance to one or more TNF blockers. It is not recommended to use upadatinib in combination with other JAKinhibitors, biological DMARDs or potent immunosuppressives (such as azathioprine and cyclosporine). Upadacitinib(Upadacitinib)How effective is it in treating psoriatic arthritis?

Two studies involving2000multiple previously treated patients with active psoriatic arthritis showed that upapatinib alone or in combination with methotrexate was more effective than adalimumab (another drug used for psoriatic arthritis) or placebo in reducing disease symptoms. After 12 weeks of treatment, 57-71% of patients taking upapatinib (dose 15 mg) experienced symptom relief, compared with 65% of patients taking upatinib and 24-36% of those taking placebo. The effect of treating psoriatic arthritis is promising.

Upadatinib is a Janus kinase (JAK) inhibitor. JAK is an intracellular enzyme that transmits signals generated by the interaction of cytokines or growth factor - receptors on the cell membrane to affect cellular processes of hematopoietic and immune cell function. In the signaling pathway, JAKphosphorylates and activates signal transducers and activators of transcription (STATs),regulating intracellular activities, including gene expression. Upatinib regulates the signaling pathway at JAKs points and prevents the phosphorylation and activation of STATs. There are generic drugs in Bangladesh, the retail price is more than 15mg for 30 tablets7 more than 100. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.